Schneider PA, Laird JR, Tepe G, Brodmann M, Zeller T, Scheinert D, et al. Treatment effect of drug coated balloons is durable to 3years in the femoropopliteal arteries: long term results of the INPACT SFA Randomized Trial. Circ Cardiovasc Interv. 2018;11:e005891.

Article  PubMed  PubMed Central  Google Scholar 

Gray WA, Keirse K, Soga Y, Benko A, Babaev A, Yokoi Y, et al. A polymer-coated, paclitaxel eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial. Lancet. 2018;392:1541–51.

Article  CAS  PubMed  Google Scholar 

Armstrong EJ, Jeon-Slaughter H, Kahlon RS, Niazi KA, Shammas NW, Banerjee S. Comparative outcomes of supera interwoven nitinol vs bare nitinol stents for the treatment of femoropopliteal disease: insights from the XLPAD registry. J Endovasc Ther. 2020;27:60–5.

Article  PubMed  Google Scholar 

Davaine JM, Quérat J, Guyomarch B, Brennan MA, Costargent A, Chaillou P, et al. Incidence and the clinical impact of stent fractures after primary stenting for TASC C and D femoropopliteal lesions at 1 year. Eur J Vasc Endovasc Surg. 2013;46:201–12.

Article  CAS  PubMed  Google Scholar 

Tsujimura T, Takahara M, Iida O, Hiramori S, Hayakawa N, Karashima E, et al. One-year clinical outcomes following implantation of InnovaTM self-expanding nitinol stents in patients with peripheral artery diseases presenting femoropopliteal artery lesions. J Atheroscler Thromb. 2019;26:847–55.

Article  PubMed  PubMed Central  Google Scholar 

Gostev AA, Osipova OO, Cheban AV, Saaya SB, Rubtsun AA, Ignatenko PV, et al. Treatment of long femoropopliteal occlusive lesions with self-expanding interwoven nitinol stent: 24 month outcomes of the STELLA-SUPERA-SIBERIA register trial. J Endovasc Ther. 2023;2:15266028231170124.

Google Scholar 

Giannopoulos S, Strobel A, Rudofker E, Kovach C, Kokkosis AA, Armstrong EJ. Outcomes of stented vs nonstented femoropopliteal lesions treated with drug-coated balloon angioplasty. J Endovasc Ther. 2023;30:194–203.

Article  PubMed  Google Scholar 

Kum S, Ipema J, Huizing E, Tan YK, Lim D, Lok IY, et al. Outcomes of the paclitaxel-eluting Eluvia stent for long femoropopliteal lesions in Asian patients with predominantly chronic limb-threatening ischemia. Vasc Med. 2021;26:267–72.

Article  CAS  PubMed  Google Scholar 

Aboyans V, Ricco JB, Bartelink MEL, Björck M, Brodmannet M, Cohnert T, et al. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS) document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Endorsed by the European Stroke Organization (ESO), the task force for the diagnosis and treatment of peripheral arterial diseases of the European Society of Cardiology (ESC), and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018;39:763–816.

Article  PubMed  Google Scholar 

Rogers JH, Lasala JM. Coronary artery dissection and perforation complicating percutaneous coronary intervention. J Invasive Cardiol. 2004;16:493–9.

PubMed  Google Scholar 

Conte MS, Bradbury AW, Kolh P, White JV, Dick F, Fitridge R, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg. 2019;69:3S-125S.

Article  PubMed  PubMed Central  Google Scholar 

Rocha-Singh KJ, Zeller T, Jaff MR. Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications. Catheter Cardiovasc Interv. 2014;83:E212–20.

Article  PubMed  Google Scholar 

Bhatt H, Kovach R, Janzer S, George JC. SUPERA stent outcomes in Above-The-Knee IntervEntions: Effects of COMPression and ELongation (SAKE-COMPEL) Sub-study. Cardiovasc Revasc Med. 2018;19:512–5.

Article  PubMed  Google Scholar 

Patel MR, Conte MS, Cutlip DE, Dib N, Geraghty P, Gray W, et al. Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC). J Am Coll Cardiol. 2015;65:931–41.

Article  PubMed  PubMed Central  Google Scholar 

Iida O, Takahara M, Soga Y, Fujihara M, Kawasaki D, Hirano K, et al. A novel angiographic risk score for femoropopliteal interventions. J Endovasc Ther. 2020;27:967–73.

Article  PubMed  Google Scholar 

Davaine JM, Querat J, Kaladji A, Guyomarch B, Chaillou P, Costargent A, et al. Treatment of TASC C and D femoropoliteal lesions with paclitaxel eluting stents: 12 month results of the STELLA-PTX registry. Eur J Vasc Endovasc Surg. 2015;50:631–7.

Article  CAS  PubMed  Google Scholar 

Suzuki K, Ueshima D, Higashitani M, Yamauchi Y, Hozawa K, Hayakawa N, et al. Two-year results of endovascular therapy for femoropopliteal arterydisease in Japan during the introduction of drug-eluting devices. Cardiovasc Interv Ther. 2023;38:113–20.

Article  CAS  PubMed  Google Scholar 

Iida O, Takahara M, Soga Y, Yamaoka T, Fujihara M, Kawasaki D, et al. 1-Year outcomes of fluoropolymer-based drug-eluting stent in femoropopliteal practice: predictors of restenosis and aneurysmal degeneration. JACC Cardiovasc Interv. 2022;15:630–8.

Article  PubMed  Google Scholar 

Bisdas T, Beropoulis E, Argyriou A, Torsello G, Stavroulakis K. 1-Year All-comers analysis of the eluvia drug-eluting stent for long femoropopliteal lesions after suboptimal angioplasty. JACC Cardiovasc Interv. 2018;11:957–66.

Article  PubMed  Google Scholar 

Tan M, Takahara M, Soga Y, Mori S, Tsuchiya T, Mazaki T, et al. Three-year clinical outcomes following implantation of LifeStent self-expanding nitinol stents in patients with femoropopliteal artery lesions. Angiology. 2022;73:244–51.

Article  CAS  PubMed  Google Scholar 

Scheinert D, Micari A, Brodmann M, Tepe G, Peeters P, Jaff MR, et al. Drug-coated balloon treatment for femoropopliteal artery disease. Circ Cardiovasc Interv. 2018;11:e005654.

Article  PubMed  Google Scholar 

Soga Y, Takahara M, Iida O, Tomoi Y, Kawasaki D, Tanaka A, et al. Vessel patency and associated factors of drug-coated balloon for femoropopliteal lesion. J Am Heart Assoc. 2023;12:e025677.

Article  PubMed  Google Scholar 

Fujihara M, Takahara M, Iida O, Kawasaki D, Soga Y, Tobita K, et al. Endovascular therapy with interwoven nitinol stent placement after predilation for heavily calcified femoropopliteal artery disease: results of the BURDOCK study. J Vasc Interv Radiol. 2023;S1051–0443(23):00561–4.

Google Scholar